FDA Denies Approval of MDMA-Assisted Therapy for PTSD
AJN, American Journal of Nursing – November 01, 2024
Source: CrossRef
Summary
For many battling PTSD, standard therapies fall short. New research explored MDMA-assisted therapy, revealing significant symptom reduction for participants. Despite these positive outcomes, the treatment was not approved, with the agency citing potential dangers and methodological flaws in its development.
Abstract
The agency cited potential dangers and flaws in research methodology.